PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
Phospho-PKC (pan) (beta II Ser660) Antibody
#9371 · $150
100
Citing papers
5.2k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Extracellular vesicles in disease
13
Peroxisome Proliferator-Activated Receptors
8
Circular RNAs in diseases
6
MicroRNA in disease regulation
5
Autophagy in Disease and Therapy
5
Cancer, Hypoxia, and Metabolism
5
Cannabis and Cannabinoid Research
4
Adipose Tissue and Metabolism
4
Papers citing this product
1
Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation
BMC Cancer
·
2010
·
293 cit.
·
DOI
2
IκB Kinase Regulates Social Defeat Stress-Induced Synaptic and Behavioral Plasticity
Journal of Neuroscience
·
2011
·
271 cit.
·
DOI
3
Homocysteine directly interacts and activates the angiotensin II type I receptor to aggravate vascular injury
Nature Communications
·
2017
·
255 cit.
·
DOI
4
Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes
Diabetologia
·
2019
·
247 cit.
·
DOI
5
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
Science Advances
·
2023
·
183 cit.
·
DOI
6
Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway
Autophagy
·
2019
·
183 cit.
·
DOI
7
25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome
Nature Communications
·
2016
·
163 cit.
·
DOI
8
Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands
Molecular Pharmacology
·
2011
·
152 cit.
·
DOI
9
Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
Frontiers in Immunology
·
2020
·
148 cit.
·
DOI
10
Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers
American Journal of Hematology
·
2018
·
120 cit.
·
DOI
Show 90 more papers
Feedback